Jiangsu Hengrui Pharmaceuticals Receives NMPA Approval for Two Autoimmune Disease Drug Candidates
China-based Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has separately announced clinical trial approvals from the National...
Sino-US Laekna Receives FDA Clearance for LAE102 Clinical Trial in NSCLC
Sino-US Laekna has announced that it has received clinical trial clearance from the US Food...
Beijing Hospitals to Pilot DRG-VBP Reforms for Medical Consumables Procurement
The Beijing Municipal Medical Insurance Bureau has released a notification indicating that six hospitals in...
Lundbeck A/S Reports Record Quarterly Revenue in Q1 2023 with 11% YOY Increase
Denmark-based pharmaceutical company Lundbeck A/S (OTCMKTS: HLUBF) has released its financial report for the first...
Cabaletta Bio’s CABA-201 Clears FDA for Phase I/II Study in Idiopathic Inflammatory Myopathy
US-based Cabaletta Bio, Inc. (NASDAQ: CABA) has announced that the US Food and Drug Administration...
MicroPort Scientific Plans IPO for Subsidiary MicroPort CRM on Hong Kong Stock Exchange
Shanghai-based medical device giant MicroPort Scientific Corp. (HKG: 0853) has announced its intention to spin...
Mustang Bio, Inc. Enters Strategic Partnership with uBriGene for Cell and Gene Therapy
US-based Mustang Bio, Inc. has announced a strategic partnership with uBriGene (Boston) Biosciences Inc., the...
Beijing Sun-Novo Secures Exclusive Rights to Kaneka’s Skin Patch Drugs in Licensing Deal
China-based Beijing Sun-Novo Pharmaceutical Research Co., Ltd (SHA: 688621) has announced a licensing agreement with...
International Vaccine Institute and Nankai University Establish Joint Research Center for Vaccine Advancements
The International Vaccine Institute (IVI), a non-profit international organization initiated by the United Nations Development...
MicroPort MedBot Receives NMPA Approval for Mona Lisa Prostate Puncture Robot System
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced that it has received marketing...
Liaoning-Led Alliance Launches Volume-Based Procurement Tender for Hernia and Dural Patches
A 12-strong provincial procurement alliance, spearheaded by Liaoning province, has announced the initiation of a...
Asieris Pharmaceuticals Secures Exclusive Global Rights to UroViu’s Fluorescent Imaging Cystoscope
China-based urogenital cancer specialist Asieris Pharmaceuticals (SHA: 688176) has announced a strategic collaboration with US...
Abbisko Therapeutics and X4 Pharmaceuticals Announce Positive Phase III Results for Mavorixafor in WHIM Syndrome
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) and its US partner X4 Pharmaceuticals Inc....
Shenzhen Kangtai Biological Partners with Saudi Importer for Pneumonia Vaccine Distribution
China-based Shenzhen Kangtai Biological Products Co., Ltd (SHE: 300601) has announced a strategic partnership with...
FibroGen’s Roxadustat Shows Positive Results in Phase III Chemotherapy-Induced Anemia Trial
US-based FibroGen Inc. (NASDAQ: FGEN) has announced positive topline data from a Phase III trial...
GenScipt Biotech Corp. Expands Oligonucleotide and Peptide Manufacturing in Zhenjiang
China-based Contract Development and Manufacturing Organization (CDMO) GenScipt Biotech Corp. (HKG: 1548) has revealed the...
NMPA Approves Nanjing Sanhome’s Alfosbuvir for Chronic Hepatitis C Treatment
Nanjing Sanhome Pharmaceutical Co., Ltd has announced that its Category 1 drug alfosbuvir has been...
Betta Pharmaceuticals Initiates Phase I/II Study for First-In-Class BsAb BPB-101
China’s Betta Pharmaceuticals (SHE: 300558) has announced the enrollment of the first patient in a...
Antengene’s First-in-Class CD24 mAb ATG-031 Gets US FDA Approval for Phase I Study
Antengene Corp., Ltd (HKG: 6996) has announced that it has received approval from the US...
BioRay Pharmaceutical’s Zuberitamab Approved by NMPA for CD20 Positive DLBCL Treatment
BioRay Pharmaceutical Co., Ltd has announced that its drug zuberitamab has been approved by the...